Medical Devices industry M&A deals total $2.41bn in North America in March 2021

Total medical devices industry M&A deals worth $2.41bn were announced in North America in March 2021, led by Agilent Technologies‘ $695m acquisition of Resolution Bioscience, according to GlobalData’s deals database.

The value marked an increase of 1.3% over the previous month of $2.38bn and a drop of 66.1% when compared with the last 12-month average of $7.11bn.

North America held a 62.44% share of the global medical devices industry M&A deal value that totalled $3.86bn in March 2021. With a 57.77% share and deals worth $2.23bn, the US was the top country in North America’s M&A deal value across medical devices industry.

In terms of M&A deal activity, North America recorded 26 deals during March 2021, marking a decrease of 21.21% over the previous month and a rise of 8.33% over the 12-month average. The US recorded 23 deals during the month.

North America medical devices industry M&A deals in March 2021: Top deals

The top five medical devices industry M&A deals accounted for 79.7% of the overall value during March 2021.

The combined value of the top five medical devices deals stood at $1.92bn, against the overall value of $2.41bn recorded for the month.

The top five medical devices industry M&A deals of March 2021 tracked by GlobalData were:

1) Agilent Technologies’ $695m acquisition of Resolution Bioscience

2) The $475m acquisition of Northfield Medical by Agiliti

3) Bio Techne’s $320m acquisition of Asuragen

4) The $240m acquisition of Alydia Health by Organon &

5) Specialists On Call’s acquisition of Access Physicians for $194m.